These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 33566325)

  • 21. Association between Bone Mineral Density of Femoral Neck and Geriatric Nutritional Risk Index in Rheumatoid Arthritis Patients Treated with Biological Disease-Modifying Anti-Rheumatic Drugs.
    Tokumoto H; Tominaga H; Arishima Y; Jokoji G; Akimoto M; Ohtsubo H; Taketomi E; Sunahara N; Nagano S; Ishidou Y; Komiya S; Setoguchi T
    Nutrients; 2018 Feb; 10(2):. PubMed ID: 29463015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular risk in rheumatic patients: the link between inflammation and atherothrombosis.
    Di Minno MN; Iervolino S; Lupoli R; Russolillo A; Coppola A; Peluso R; Scarpa R; Di Minno G
    Semin Thromb Hemost; 2012 Jul; 38(5):497-505. PubMed ID: 22399309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rheumatic complications of checkpoint inhibitors: Lessons from autoimmunity.
    Reynolds G
    Immunol Rev; 2023 Sep; 318(1):51-60. PubMed ID: 37435963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infection risk in patients undergoing treatment for inflammatory arthritis: non-biologics versus biologics.
    Chiu YM; Chen DY
    Expert Rev Clin Immunol; 2020 Feb; 16(2):207-228. PubMed ID: 31852268
    [No Abstract]   [Full Text] [Related]  

  • 25. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
    Goodman SM; Springer B; Guyatt G; Abdel MP; Dasa V; George M; Gewurz-Singer O; Giles JT; Johnson B; Lee S; Mandl LA; Mont MA; Sculco P; Sporer S; Stryker L; Turgunbaev M; Brause B; Chen AF; Gililland J; Goodman M; Hurley-Rosenblatt A; Kirou K; Losina E; MacKenzie R; Michaud K; Mikuls T; Russell L; Sah A; Miller AS; Singh JA; Yates A
    Arthritis Rheumatol; 2017 Aug; 69(8):1538-1551. PubMed ID: 28620948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Rheumatic diseases in pregnancy].
    Märker-Hermann E; Bauer H; Gromnica-Ihle E
    Dtsch Med Wochenschr; 2008 Nov; 133(46):2410-4. PubMed ID: 18988134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nutritional status, body composition, and quality of life in community-dwelling sarcopenic and non-sarcopenic older adults: A case-control study.
    Verlaan S; Aspray TJ; Bauer JM; Cederholm T; Hemsworth J; Hill TR; McPhee JS; Piasecki M; Seal C; Sieber CC; Ter Borg S; Wijers SL; Brandt K
    Clin Nutr; 2017 Feb; 36(1):267-274. PubMed ID: 26689868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD.
    Hasseli R; Mueller-Ladner U; Schmeiser T; Hoyer BF; Krause A; Lorenz HM; Regierer AC; Richter JG; Strangfeld A; Voll RE; Pfeil A; Schulze-Koops H; Specker C
    RMD Open; 2020 Sep; 6(2):. PubMed ID: 32878994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of infection other than tuberculosis in patients with autoimmune rheumatic diseases treated with bDMARDs: a real-time clinical experience from India.
    Chandrashekara S; Shobha V; Rao V; Desai A; Jois R; Dharmanand BG; Kumar S; Kumar P; Dharmapalaiah C; Mahendranath KM; Prasad S; Daware MA; Singh Y; Karjigi U; Nagaraj S; Anupama KR
    Rheumatol Int; 2019 Mar; 39(3):497-507. PubMed ID: 30684040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adherence of rheumatoid arthritis patients to biologic disease-modifying antirheumatic drugs: a cross-sectional study.
    Mena-Vazquez N; Manrique-Arija S; Yunquera-Romero L; Ureña-Garnica I; Rojas-Gimenez M; Domic C; Jimenez-Nuñez FG; Fernandez-Nebro A
    Rheumatol Int; 2017 Oct; 37(10):1709-1718. PubMed ID: 28631046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of healthcare resources in a cohort of rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs or tofacitinib.
    Machado-Alba JE; Machado-Duque ME; Gaviria-Mendoza A; Reyes JM; Gamboa NC
    Clin Rheumatol; 2021 Apr; 40(4):1273-1281. PubMed ID: 32997316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum vitamin D status inversely associates with a prevalence of severe sarcopenia among female patients with rheumatoid arthritis.
    Minamino H; Katsushima M; Torii M; Yamamoto W; Fujita Y; Ikeda K; Okamura E; Murakami K; Watanabe R; Murata K; Ito H; Tanaka M; Arai H; Matsuda S; Morinobu A; Inagaki N; Hashimoto M
    Sci Rep; 2021 Oct; 11(1):20485. PubMed ID: 34650186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prescribing Trends of Biologic Disease-Modifying Anti-rheumatic Drugs Using a Claims Database from 6 Million People in Japan.
    Hirata A; Ota R; Hata T; Hamada T; Nishihara M; Uchiyama K; Katsumata T
    Clin Drug Investig; 2021 Nov; 41(11):967-974. PubMed ID: 34553318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Useful message in choosing optimal biological agents for patients with autoimmune arthritis.
    Lai JH; Ling XC; Ho LJ
    Biochem Pharmacol; 2019 Jul; 165():99-111. PubMed ID: 30876919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of obesity on the efficacy of different biologic agents in inflammatory diseases: A systematic review and meta-analysis.
    Shan J; Zhang J
    Joint Bone Spine; 2019 Mar; 86(2):173-183. PubMed ID: 29635017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of biological DMARDs on the risk of congestive heart failure in rheumatoid arthritis: a systematic review.
    Baniaamam M; Paulus WJ; Blanken AB; Nurmohamed MT
    Expert Opin Biol Ther; 2018 May; 18(5):585-594. PubMed ID: 29623726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment patterns and sequencing in patients with rheumatic diseases: a retrospective claims data analysis.
    Gauthier G; Levin R; Vekeman F; Reyes JM; Chiarello E; Ponce de Leon D
    Curr Med Res Opin; 2021 Dec; 37(12):2185-2196. PubMed ID: 34544301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-nuclear antibody development is associated with poor treatment response to biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis.
    Ishikawa Y; Hashimoto M; Ito H; Tanaka M; Yukawa N; Fujii T; Yamamoto W; Mimori T; Terao C
    Semin Arthritis Rheum; 2019 Oct; 49(2):204-210. PubMed ID: 30803720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lower concentration of vitamin D is associated with lower DAS28 and VAS-pain scores in patients with inflammatory rheumatic diseases treated with infliximab: a pilot study.
    Miler M; Nikolac Gabaj N; Grazio S; Vahtarić A; Vrtarić A; Grubišić F; Skala Kavanagh H; Doko Vajdić I; Vrkić N
    Rheumatol Int; 2020 Sep; 40(9):1455-1461. PubMed ID: 32462255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Putative effects of potentially anti-angiogenic drugs in rheumatic diseases.
    Maruotti N; Cantatore FP; Ribatti D
    Eur J Clin Pharmacol; 2014 Feb; 70(2):135-40. PubMed ID: 24196651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.